Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
3.54M
-
Shares change
-
+749K
-
Total reported value, excl. options
-
$8.72M
-
Value change
-
+$1.83M
-
Number of buys
-
22
-
Number of sells
-
-22
-
Price
-
$2.46
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q3 2025
62 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q3 2025.
ImmunityBio, Inc. - COM (IBRX) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.54M shares
.
Largest 10 shareholders include SHEETS SMITH WEALTH MANAGEMENT (633K shares), Accurate Wealth Management, LLC (560K shares), Kercheville Advisors, LLC (519K shares), Hennion & Walsh Asset Management, Inc. (307K shares), Plancorp, LLC (271K shares), COLLECTIVE FAMILY OFFICE LLC (161K shares), WEALTH EFFECTS LLC (115K shares), Sowell Financial Services LLC (104K shares), MERIDIAN INVESTMENT COUNSEL INC. (96.4K shares), and COMMONWEALTH EQUITY SERVICES, LLC (72.5K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.